Skip to main content
TipRanks
Go Ultimate75% OFF

Bioptic Inc. (6850) Financial Statements

Bioptic Inc. Financial Overview

Bioptic Inc.'s market cap is currently NT$919.86M. The company's EPS TTM is NT$0.25; its P/E ratio is 111.20; and it has a dividend yield of 1.80%. Bioptic Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 236.13MNT$ 202.69MNT$ 228.27MNT$ 231.40MNT$ 179.28M
Gross ProfitNT$ 141.66MNT$ 125.28MNT$ 152.75MNT$ 152.65MNT$ 110.38M
Operating IncomeNT$ 39.09MNT$ 19.17MNT$ 44.05MNT$ 65.00MNT$ 44.16M
EBITDANT$ 56.20MNT$ 46.62MNT$ 65.04MNT$ 88.91MNT$ 57.38M
Net IncomeNT$ 1.22MNT$ 22.73MNT$ 37.75MNT$ 61.27MNT$ 46.25M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 170.03MNT$ 98.13MNT$ 80.61MNT$ 207.22MNT$ 163.53M
Total AssetsNT$ 576.82MNT$ 596.41MNT$ 613.77MNT$ 521.44MNT$ 419.48M
Total DebtNT$ 85.70MNT$ 86.17MNT$ 93.20MNT$ 14.34MNT$ 5.86M
Net DebtNT$ -84.33MNT$ -11.95MNT$ 12.59MNT$ -192.88MNT$ -144.17M
Total LiabilitiesNT$ 125.27MNT$ 134.66MNT$ 170.56MNT$ 94.08MNT$ 44.69M
Stockholders' EquityNT$ 441.85MNT$ 449.72MNT$ 431.77MNT$ 418.50MNT$ 368.09M
Cash Flow
Free Cash FlowNT$ 86.81MNT$ 24.27MNT$ -126.87MNT$ 62.60MNT$ 24.74M
Operating Cash FlowNT$ 89.35MNT$ 31.05MNT$ -12.75MNT$ 69.47MNT$ 32.43M
Investing Cash FlowNT$ -2.97MNT$ -2.15MNT$ -159.04MNT$ 2.24MNT$ -7.72M
Financing Cash FlowNT$ -14.43MNT$ -12.53MNT$ 45.94MNT$ -14.75MNT$ 62.72M

Currency in TWD

Bioptic Inc. Earnings and Revenue History

0100M200M300M0 %10 %20 %30 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin

Bioptic Inc. Liabilities to Assets

0250M500M750M0 %15 %30 %45 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Bioptic Inc. Cash Flow

-200M-150M-100M-50M050M100M150M202020212022202320242025OperatingInvestingFinancing

Bioptic Inc. Forecast EPS vs Actual EPS